In Vitro and in Vivo Anti-Inflammatory Activity of the New Glucocorticoid Ciclesonide

Journal of Pharmacology and Experimental Therapeutics

Volumn 309, Issue 1, 2004, Pages 249-258

  Stoeck, Michael ^a,d   Riedel, Richard ^a   Hochhaus, Günther ^b   Häfner, Dietrich ^a   Masso, José M ^c   Schmidt, Beate ^a   Hatzelmann, Armin ^a   Marx, Degenhard ^a   Bundschuh, Daniela S ^a  

^a ALTANA Pharma   (Germany)

^b UNIVERSITY OF FLORIDA HEALTH   (United States)

^c Elmuquimica Pharmaceutica   (Spain)

^d ALTANA PHARMA AG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

2' CYCLOHEXYL 11BETA HYDROXY 21 ISOBUTYRYLOXY 16BH DIOXOLO[5',4':16,17]PREGNA 1,4 DIENE 3,20 DIONE; BRADYKININ; BUDESONIDE; BYK 20426; BYK 20427; BYK 20432; BYK 20433; CICLESONIDE; CONCANAVALIN A; DESISOBUTYRYLCICLESONIDE; DEXAMETHASONE; DRUG METABOLITE; ESTERASE; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; ISOBUTYRIC ACID; OVALBUMIN; PREGNANE DERIVATIVE; PROTEIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADRENAL GLAND; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DOSE RESPONSE; DRUG BIOAVAILABILITY; DRUG POTENCY; EOSINOPHIL; EPIMER; GRANULOMA; IN VITRO STUDY; IN VIVO STUDY; LUNG LAVAGE; LYMPHOCYTE; MALE; NONHUMAN; ORGAN WEIGHT; PRIORITY JOURNAL; RAT; SPLEEN CELL; THYMUS; TRACHEA;

ADMINISTRATION, ORAL; ADMINISTRATION, TOPICAL; ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIGENS, CD3; ANTINEOPLASTIC AGENTS; BINDING SITES; BRADYKININ; CD4-POSITIVE T-LYMPHOCYTES; CELL DIVISION; CONCANAVALIN A; CYTOKINES; GLUCOCORTICOIDS; GRANULOMA; HUMANS; INTERLEUKIN-4; INTERLEUKIN-5; LEUKOCYTES, MONONUCLEAR; LUNG; MALE; NEOPLASM TRANSPLANTATION; NEOPLASMS, EXPERIMENTAL; PREGNENEDIONES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, GLUCOCORTICOID; SPLEEN; TRACHEA;

EID: 1642340164     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.103.059592     Document Type: Article

References (35)

1. Adcock IM (2001) Glucocorticoid-regulated transcription factors. Pulm Pharmacol Ther 14:211-219.
2. Bachert C and Geveart P (1999) Effect of intranasal corticosteroids on release of cytokines and inflammatory mediators. Allergy 54 (Suppl) 57:116-123.
3. Barnes PJ (1995) Inhaled glucocorticoids for asthma. N Engl J Med 332:868-875.
4. Belvisi MG, Brown TJ, Wicks S, and Foster ML (2001) New glucocorticosteroids with an improved therapeutic ratio? Pulm Pharmacol Ther 14:221-227.
5. Belvisi MG, Bundschuh DS, Stoeck M, Wicks S, Underwood S, Battram CH, Webber SE, Haddad E-B, and Foster ML (2002) Ciclesonide, a novel 'on-site activated' inhaled corticosteroid with potent anti-inflammatory activity. J Allergy Clin Immunol 109:A59.
6. Ben Rhouma K and Sakly M (1994) Involution of rat thymus: characterization of cytoplasmic glucocorticoid receptors, evidence of glucocorticoid resistant dexamethasone receptor-positive cells. Arch Int Physiol Biochim Biophys 102:97-102.
7. Bentley AM, Hamid Q, Robinson DS, Schotman E, Meng Q, Assoufi B, Kay AB, and Durham SR (1996) Prednisolone treatment in asthma. Reduction in the numbers of eosinophils, T cells, tryptase-only positive mast cells, and modulation of IL-4, IL-5 and interferon-gamma cytokine gene expression within the bronchial mucosa. Am J Respir Crit Care Med 153:551-556.
8. Bodor N (1988) The application of soft drug approaches to design safer steroids, in Topical Corticosteroid Ttherapy: A Novel Approach to Safer Drugs (Christopher E ed) pp 13-25, Raven Press, New York.
9. Boschetto P, Rogers DF, Fabbri LM, and Barnes PJ (1991) Corticosteroid inhibition of airway microvascular leakage. Am Rev Respir Dis 143:605-609.
10. Brattsand R, O'Donnell SR, Miller-Larsson A, and Rauchle KL (1991) Attenuation of bradykinin-induced mucosal inflammation by topical budesonide in rat trachea. Agents Actions 34:200-202.
11. Bundschuh DS, Eltze M, Barsig J, Wollin L, Hatzelmann A, and Beume R (2001) In vivo efficacy in airway disease models of roflumilast, a novel orally active PDE4 inhibitor. J Pharmacol Exp Ther 297:280-290.
12. Burke C, Power CK, Norris A, Condez A, Schmekel B, and Poulter LW (1992) Lung function and immunopathological changes after inhaled corticosteroid therapy in asthma. Eur Respir J 5:73-79.
13. Chanoine F, Grenot C, Heidmann P, and Junien JL (1991) Pharmacokinetics of butixocort 21-propionate, budesonide, and beclomethasone dipropionate in the rat after intratracheal, intravenous and oral treatments. Drug Metab Dispos 19:546-553.
14. Elwood W, Lotvall JO, Barnes PJ, and Chung KF (1991) Characterization of allergen-induced bronchial hyperresponsiveness and airway inflammation in actively sensitized brown-Norway rats. J Allergy Clin Immunol 88:951-960.
15. Gantner F, Tenor H, Gekeler V, Schudt C, Wendel A, and Hatzelmann A (1997) Phosphodiesterase profiles of highly purified human peripheral blood leukocyte populations from normal and atopic individuals: a comparative study. J Allergy Clin Immunol 100:527-535.
16. Giembycz MA (2000) Phosphodiesterase 4 inhibitors and the treatment of asthma: where are we now and where do we go from here? Drugs 59:193-212.
17. Gillis S, Crabtree GR, and Smith KA (1979) Glucocorticoid-induced inhibition of T cell growth factor production. I. The effect on mitogen-induced lymphocyte proliferation. J Immunol 123:1624-1631.
18. Hall M, Peet CF, Boddington TKS, Enos T, Nave R, and Zech K (2000) Enzymology of the human hepatic metabolism of ciclesonide (B9207-015) (Abstract). Xenobiotic Metab Dispos 15 (Suppl):11PE-12PE.
19. Lenschow DJ, Walunas TL, and Bluestone JA (1996) CD28/B7 system of T cell costimulation. Annu Rev Immunol 14:233-258.
20. Lord CJ and Lamb JR (1996) TH2 cells in allergic inflammation: a target of immunotherapy. Clin Exp Allergy 26:756-765.
21. Loux JJ, Smith S, and Salem H (1977) Antiinflammatory activity: evaluation of a new screening procedure. Inflammation 2:125-130.
22. Manz B, Grill HJ, and Pollow K (1982) Steroid side-chain modification and receptor affinity: binding of synthetic derivatives of corticoids to human spleen tumor and rat liver glucocorticoid receptors. J Steroid Biochem 17:335-342.
23. Mealy NE, Bayes M, and Castaner J (2001) Ciclesonide. Drugs Future 26:1033-1039.
24. Mutch E, Nave R, Zech K, and Williams FM (2003) Esterases involved in the hydrolysis of ciclesonide in human tissues. Eur Respir J 22 (Suppl 45):P1749.
25. 14C-ciclesonide after oral and intravenous administration in healthy subjects. Eur Respir J 20 (Suppl 38):P745.
26. Rohdewald P, Möllmann HW, and Hochhaus G (1984) Rezeptoraffinitäten handelsüblicher Glukokortikoide zum Glukokortikoid-Rezeptor der menschlichen Lunge. Atemw-Lungenkrkh 10:484-489.
27. Salvi SS, Babu KS, and Holgate ST (2001) Is asthma really due to a polarized T cell response toward a helper T cell type 2 phenotype? Am J Respir Crit Care Med 164:1343-1346.
28. Schneider T, van Velzen D, Moqbel R, and Issekutz AC (1997) Kinetics and quantitation of eosinophil and neutrophil recruitment to allergic lung inflammation in a brown Norway rat model. Am J Respir Cell Mol Biol 17:702-712.
29. Skoner DP (2001) Allergic rhinitis: definition, epidemiology, pathophysiology, detection and diagnosis. J Allergy Clin Immunol 108:S2-S8.
30. Smith KA, Crabtree GR, Kennedy SJ, and Munck AU (1977) Glucocorticoid receptors and glucocorticoid sensitivity of mitogen stimulated and unstimulated human lymphocytes. Nature (Lond) 267:523-526.
31. Stoeck M, Hatzelmann A, Belvisi MG, Foster ML, and Bundschuh DS (2001) In vitro anti-inflammatory activity of the new glucocorticoid ciclesonide in human cells (Abstract). Eur Respir J 18 (Suppl 33):P679.
32. Szelenyi I, Hochhaus G, Heer S, Küsters S, Marx D, Poppe H, and Engel J (2000) Loteprednol etabonate: a soft steroid for the treatment of allergic diseases of the airways. Drugs Today 36:313-320.
33. Toogood JH (1998) Side effects of inhaled corticosteroids. J Allergy Clin Immunol 102:705-713.
34. Winter CA, Risley EA, and Nuss GW (1963) Anti-inflammatory and antipyretic activities of indomethacin, 1-(p-chlorobenzoyl)-5-methoxy-2-methylindole-3-acetic acid. J Pharmacol Exp Ther 141:369.
35. Wuerthwein G, Rehder S, and Rohdewald P (1992) Lipophilicity and receptor affinity of glucocorticoids. Pharm Ztg Wiss 137:161-165.